Cardiac Implant Market to Surpass US$ 83.7 Billion by 2026 - Coherent Market Insights

Published On : Jul 18, 2019

The global cardiac implant market, by Device (Pacemaker Devices, Cardiac Resynchronization Therapy Devices, Implantable Hemodynamic Monitoring Devices, Implanted Heart Rhythm Monitors, Coronary Stents, Implantable Cardioverter Defibrillator, Heart Valve and Others ), by Application (Arrhythmias, Myocardial Ischemia, Acute Myocardial Infraction, Congestive Heart Failure, and Others), by End User (Hospitals, Emergency Medical Centers, Ambulatory Surgical Center, Home Care Settings, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 34,783.4  million in 2018, and is projected to exhibit a CAGR of 11.6%, during the forecast period (2019-2026), as highlighted in a new report published by Coherent Market Insights.

Increasing adoption of inorganic growth strategies such as partnerships and collaborations by key players and healthcare providers to enhance their cardiac devices portfolio is expected to contribute to growth of the global cardiac implant market. For instance, in December 2018, Ochsner Health System and Geneva Health Solutions (GHS) entered a strategic partnership. Under this partnership, GHS’ cloud-based technology platform and remote monitoring service for patients with cardiac implants will be utilized by Ochsner’s patients in specific states including Louisiana, Arkansas, Mississippi, Alabama and Georgia.

Moreover, launch of innovative technologies supporting cardiac implants is driving the market growth. For instance, in May 2019, Abbott launched the Confirm RX Implantable Cardiac Monitor, which is a new, smarter heart monitor for better arrhythmia detection. The device is designed for patients who are at risk of irregular heartbeats. Abbots received the CE marking for the Confirm RX Implantable Cardiac Monitor (ICM) in May 2017, allowing the company to market the product in the Europe market.

Browse 32 Market Data Tables and 30 Figures spread through 173 Pages and in-depth TOC on "Cardiac Implant Market, by Device (Pacemaker Devices, Cardiac Resynchronization Therapy Devices, Implantable Hemodynamic Monitoring Devices, Implanted Heart Rhythm Monitors, Coronary Stents, Implantable Cardioverter Defibrillator, Heart Valve, and Others), by Application (Arrhythmias, Myocardial Ischemia, Acute Myocardial Infraction, Congestive Heart Failure, and Others), by End User (Hospitals, Emergency Medical Centers, Ambulatory Surgical Center, Home Care Settings, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Global Forecast to 2026"

To know the latest trends and insights related to Cardiac Implant market, click the link below:

https://www.coherentmarketinsights.com/market-insight/cardiac-implants-market-1176

Rising investments by key players in order to develop innovative cardiac implantable devices is expected to be another driving factor for the cardiac implant market growth. For instance, in August 2016, V-Wave, an Israel-based startup which specializes in implantable devices for chronic heart failure (CHF), received a US$ 28 million investment from Johnson & Johnson Innovation (JJDC). This investment is expected to fund the clinical trials that are being conducted for cardiac devices to get regulatory approval in the U.S. Moreover, the V-Wave implant was developed in Israel, and since 2014 over 30 patients successfully were implanted with the device.

However, increasing number product recalls for cardiac implants is expected to hamper growth of the cardiac implant market. For instance, in March 2019, U.S. Food and Drug Administration issued a product recall notice for implantable electrophysiology (EP) cardiac devices, developed by Medtronic Plc plc, due to some cybersecurity vulnerabilities in the wireless telemetry technology used for communication between the device and their programming and monitoring systems. Many manufacturers are currently emphasizing on security issues in designing the products.

Key Takeaways of the Global Cardiac Implant Market:

  • The global cardiac implant market is expected to expand at a CAGR of 11.6% during the forecast period (2019–2026), owing to increasing initiatives by key players to develop prominent technologies for better patient outcomes. For instance, in March 2019, Biotronik launched the world’s smallest implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) in Europe. Both products are approved for 3 Tesla (3T) full-body MRI scans.
  • Increasing number of acquisitions by key players for expansion of cardiovascular devices product portfolio is expected to drive the global cardiac implant market growth. For instance, in January 2017, Abbott acquired St. Jude Medical, Inc. The acquisition of St. Jude Medical has strengthened Abbott’s presence in global medical device while offering innovative products to address more areas of care, in a large number of hospitals around the world.
  • Major players operating in the global cardiac implant market include Medtronic Plc, Inc. Boston Scientific Corporation, Abbott Vascular Inc., Edwards LifeScience Corporation, Thoractec Corporation, Syncardia systems, Inc., Biotronik, B. Braun Melsungen AG, and LivaNova PLC.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.